CareDx (CDNA) Net Equity Issued and Repurchased (2017 - 2021)

CareDx has disclosed Net Equity Issued and Repurchased across 3 years of filings, most recently posting $100000.0 for Q3 2021.

• In Q3 2021, Net Equity Issued and Repurchased rose 124.1% year-over-year to $100000.0; the TTM figure through Jun 2022 stood at $100000.0 (down 99.95% YoY), while the FY2021 annual figure was $188.9 million, up 40.22% from the prior year.
• Net Equity Issued and Repurchased came in at $100000.0 for Q3 2021 at CareDx, up from $40000.0 in the prior quarter.
• In the past five years, Net Equity Issued and Repurchased ranged from a high of $188.7 million in Q1 2021 to a low of -$415000.0 in Q3 2020.
• Average Net Equity Issued and Repurchased over 3 years is $57.3 million, with a median of $10.0 million recorded in 2017.
• The largest YoY upside for Net Equity Issued and Repurchased was 124.1% in 2021 against a maximum downside of 99.97% in 2021.
• Over 3 years, Net Equity Issued and Repurchased stood at $20.0 million in 2017, then tumbled by 102.08% to -$415000.0 in 2020, then soared by 124.1% to $100000.0 in 2021.
• Per Business Quant data, the three most recent Net Equity Issued and Repurchased figures were $100000.0 in Q3 2021, $40000.0 in Q2 2021, and $188.7 million in Q1 2021.